Documentation Centre

November 03, 2015
The evolving role of CETP inhibition: beyond HDL cholesterol. Lancet. 2015;386:412-4
Ray KK, Vallejo-Vaz AJ

Description of this Publication

Consult publication on external website

By clicking on this link, you will leave the INTERNATIONAL CHAIR ON CARDIOMETABOLIC RISK website

Key Words
Cardiovascular Disease, Documentation Centre, Lipids/Lipoproteins